IRCT20220209053979N11已完成Unknown
Bioequivalence Study of Citalopram 40 mg manufactured by Shafa Pharmaceutical and Celexa manufactured by Lundbeck in 24 Healthy Volunteers under fasting condition
Shafa Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy male or female volunteers
- •Body mass index (BMI) between 18 - 30
- •Volunteers who are willing to sign an informed consent form
排除标准
- •Familial history of heart disease
- •History of allergy to Citalopram or formulation components
- •Taking any type of medicine in the 14 days before the start of the study
- •Participation in any clinical study within 30 days prior to study
研究者
相似试验
招募中
Unknown
Investigating bioequivalence of Citalopram tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N13Tabriz University of Medical Sciences24
已完成
1 期
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsHealthyNCT01149980Dr. Reddy's Laboratories Limited24
已完成
1 期
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsHealthyNCT01149967Dr. Reddy's Laboratories Limited24
招募中
2 期
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital ICIRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
尚未招募
Unknown
Comparative in vivo evaluation of 2 Escitalopram 20 mg F.C. Tablet formulations.IRCT20180620040164N44Karen Pharma and Food Supplement Co.24